The Lab

Tevogen’s groundbreaking work in targeted T-cell therapies is rooted in two fundamental beliefs. First, the next frontier of medical innovation lies in the purposeful development of accessible, personalized immunotherapies. Second, we must look to disruptive business models to sustain medical innovation in a post-pandemic reality.